Ozempic, known generically as semaglutide, has gained significant attention recently for its effectiveness in treating Type 2 diabetes and obesity. Originally approved as a diabetes medication in 2017, Ozempic works by mimicking the effects of the GLP-1 hormone, which regulates blood sugar levels and promotes a feeling of fullness. This has made it an effective option for treating obesity, leading to its off-label use for weight management. The surge in popularity of Ozempic, particularly for weight loss, has led to …
